Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 3,697 | 2,557 | 2,409 | 2,850 | 2,159 |
| Cost of Goods | 1,586 | 1,036 | 1,647 | 1,455 | 1,106 |
| Gross Profit | 2,111 | 1,521 | 762 | 1,395 | 1,053 |
| Operating Expenses | 3,003 | 2,250 | 2,690 | 2,664 | 2,706 |
| Operating Income | -306 | -693 | -1,281 | -814 | -1,547 |
| Interest Expense | 1 | 3 | 4 | 6 | 7 |
| Other Income | 1 | -23 | 35 | 73 | -7 |
| Pre-tax Income | -306 | -719 | -1,250 | -747 | -1,561 |
| Net Income Continuous | -306 | -719 | -1,250 | -747 | -1,561 |
| Net Income Discontinuous | N/A | -129 | -1,904 | -390 | -406 |
| Minority Interests | N/A | 70 | 77 | 66 | 63 |
| Net Income | $-306 | $-918 | $-3,231 | $-1,203 | $-2,030 |
| EPS Basic Total Ops | -0.03 | -0.13 | -0.30 | -0.11 | -0.19 |
| EPS Basic Continuous Ops | -0.03 | -0.11 | -0.12 | -0.07 | -0.15 |
| EPS Basic Discontinuous Ops | N/A | -0.02 | -0.18 | -0.04 | -0.04 |
| EPS Diluted Total Ops | -0.03 | -0.13 | -0.30 | -0.11 | -0.19 |
| EPS Diluted Continuous Ops | -0.03 | -0.11 | -0.12 | -0.07 | -0.15 |
| EPS Diluted Discontinuous Ops | N/A | -0.02 | -0.18 | -0.04 | -0.04 |
| EBITDA(a) | $-252 | $-638 | $-1,181 | $-710 | $-1,455 |